MedPath

Effect of botulinum toxin injection versus placebo injection in fat pad around the heart on the incidence of intra-hospital atrial fibrillation after coronary artery bypass graft (CABG)

Phase 2
Recruiting
Conditions
Atrial fibrillation.
Unspecified atrial fibrillation
I48.91
Registration Number
IRCT20120215009014N338
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Age of 18 to 80 years,
Indication of coronary artery bypass graft

Exclusion Criteria

History of previous hear surgery,
Unstable angina or heart failure,
Chronic atrial fibrillation,
Aortic or mitral valvular disease,
Liver or renal or thyroid disorder,
Taking anti-arrhythmic medications

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intra-hospital atrial fibrillation after coronary artery bypass graft. Timepoint: Daily for 7 to 10 days. Method of measurement: With monitoring machine.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath